Back to Search
KHIEM PLATINI TO, DOCTOR OF PHARMACY
Pharmacist
NPI: 1780156943Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
0016494(OR)
Research & Publications (20)
Validation study of a portable monitoring device for identifying OSA in a symptomatic patient population.
PMID 19210658·Respirology·2009
4-observational
NKT cell subsets mediate differential proatherogenic effects in ApoE-/- mice.
PMID 19251589·Arterioscler Thromb Vasc Biol·2009
7-preclinical
Regulation of ABCG2 expression at the 3' untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell line.
PMID 18573883·Mol Cell Biol·2008
8-other
Histone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multidrug-resistant cells.
PMID 18234970·Mol Cancer Res·2008
8-other
The phosphoinositide-dependent kinase-1 inhibitor 2-amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide (OSU-03012) prevents Y-box binding protein-1 from inducing epidermal growth factor receptor.
PMID 17595327·Mol Pharmacol·2007
4-observational
Aberrant promoter methylation of the ABCG2 gene in renal carcinoma.
PMID 16954373·Mol Cell Biol·2006
8-other
Differential nephrotoxicity of cisplatin and a novel series of traditional Chinese medicine-platinum anticancer agents correlates with their chemical reactivity towards sulfur-containing nucleophiles.
PMID 16917213·Anticancer Drugs·2006
7-preclinical
The phosphorylation status of PAS-B distinguishes HIF-1alpha from HIF-2alpha in NBS1 repression.
PMID 17024177·EMBO J·2006
7-preclinical
In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by novel traditional Chinese medicine-platinum anti-cancer agents.
PMID 16096430·Anticancer Drugs·2005
4-observational
Suppression of hypoxia-inducible factor 1alpha (HIF-1alpha) transcriptional activity by the HIF prolyl hydroxylase EGLN1.
PMID 16157596·J Biol Chem·2005
7-preclinical
Synergistic interaction between platinum-based antitumor agents and demethylcantharidin.
PMID 15896457·Cancer Lett·2005
7-preclinical
Histologic study of retinitis pigmentosa due to a mutation in the RP13 gene (PRPC8): comparison with rhodopsin Pro23His, Cys110Arg, and Glu181Lys.
PMID 15126168·Am J Ophthalmol·2004
4-observational
Protein phosphatase 2A inhibition and circumvention of cisplatin cross-resistance by novel TCM-platinum anticancer agents containing demethylcantharidin.
PMID 15358284·Bioorg Med Chem·2004
4-observational
Determination of the release of hydrolyzed demethylcantharidin from novel traditional chinese medicine-platinum compounds with anticancer activity by gas chromatography.
PMID 11885572·J Chromatogr A·2002
8-other
Histopathologic study of variation in severity of retinitis pigmentosa due to the dominant rhodopsin mutation Pro23His.
PMID 12140048·Am J Ophthalmol·2002
5-case
Retinal histopathology of an autopsy eye with advanced retinitis pigmentosa in a family with rhodopsin Glu181Lys.
PMID 11124299·Am J Ophthalmol·2000
8-other
Late recurrent seminoma: 18 years after bilateral orchidectomy in patient with bilateral stage one testicular seminoma.
PMID 19488832·Int Urol Nephrol·2010
5-case
TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistance.
PMID 19003983·Int J Cancer·2009
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4849 NE 138TH AVE
PORTLAND, OR 97230 - Phone
- (503) 257-3935
Quick Facts
- NPI
- 1780156943
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile